Augmented placental production of leptin in preeclampsia: Possible involvement of placental hypoxia

Hiroko Mise, Norimasa Sagawa, Tsunekazu Matsumoto, Shigeo Yura, Hidetaka Nanno, Hiroaki Itoh, Takahide Mori, Hiroaki Masuzaki, Kiminori Hosoda, Yoshihiro Ogawa, Kazuwa Nakao

Research output: Contribution to journalArticle

243 Citations (Scopus)

Abstract

Preeclampsia (PE) is a hypertensive disorder, which develops in late pregnancy and is usually associated with placental hypoxia and dysfunction. We have recently demonstrated that leptin is a novel placenta-derived hormone in humans and suggested its significance in human pregnancy (see Ref. 19). To explore the changes in the leptin production in placenta in PE, we measured the plasma leptin level and placental leptin messenger RNA expression in pregnant women with PE. Plasma leptin levels in preeclamptic women were elevated significantly, compared with gestational age- and body mass index- matched normal pregnant women (P < 0.0001). Plasma leptin levels in the severe PE group were significantly higher than those in the mild PE group (P < 0.0001). Plasma leptin levels in preeclamptic women were reduced, soon after the placental delivery, to those expected for their body mass indices. Northern blot analysis revealed that leptin messenger RNA levels are increased in the placentas from preeclamptic women, compared with normal pregnant women. Leptin secretion was increased significantly in a human trophoblastic cell line (BeWo cells) cultured under hypoxic conditions (5% O2), compared with those cultured under standard conditions (20% O2; P < 0.01). The present study demonstrated that placental production of leptin is augmented in severe PE, probably because of placental hypoxia, thereby suggesting the possible significance of leptin as a marker of placental hypoxia in severe PE.

Original languageEnglish
Pages (from-to)3225-3229
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume83
Issue number9
DOIs
Publication statusPublished - Nov 14 1998
Externally publishedYes

Fingerprint

Leptin
Pre-Eclampsia
Placenta
Plasmas
Pregnant Women
Body Mass Index
Hypoxia
Pregnancy
Messenger RNA
Northern Blotting
Gestational Age
Cultured Cells
Cells
Hormones
Cell Line

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Augmented placental production of leptin in preeclampsia : Possible involvement of placental hypoxia. / Mise, Hiroko; Sagawa, Norimasa; Matsumoto, Tsunekazu; Yura, Shigeo; Nanno, Hidetaka; Itoh, Hiroaki; Mori, Takahide; Masuzaki, Hiroaki; Hosoda, Kiminori; Ogawa, Yoshihiro; Nakao, Kazuwa.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 83, No. 9, 14.11.1998, p. 3225-3229.

Research output: Contribution to journalArticle

Mise, H, Sagawa, N, Matsumoto, T, Yura, S, Nanno, H, Itoh, H, Mori, T, Masuzaki, H, Hosoda, K, Ogawa, Y & Nakao, K 1998, 'Augmented placental production of leptin in preeclampsia: Possible involvement of placental hypoxia', Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 9, pp. 3225-3229. https://doi.org/10.1210/jc.83.9.3225
Mise, Hiroko ; Sagawa, Norimasa ; Matsumoto, Tsunekazu ; Yura, Shigeo ; Nanno, Hidetaka ; Itoh, Hiroaki ; Mori, Takahide ; Masuzaki, Hiroaki ; Hosoda, Kiminori ; Ogawa, Yoshihiro ; Nakao, Kazuwa. / Augmented placental production of leptin in preeclampsia : Possible involvement of placental hypoxia. In: Journal of Clinical Endocrinology and Metabolism. 1998 ; Vol. 83, No. 9. pp. 3225-3229.
@article{3fc167b0fcb24bc28216ca5c25643855,
title = "Augmented placental production of leptin in preeclampsia: Possible involvement of placental hypoxia",
abstract = "Preeclampsia (PE) is a hypertensive disorder, which develops in late pregnancy and is usually associated with placental hypoxia and dysfunction. We have recently demonstrated that leptin is a novel placenta-derived hormone in humans and suggested its significance in human pregnancy (see Ref. 19). To explore the changes in the leptin production in placenta in PE, we measured the plasma leptin level and placental leptin messenger RNA expression in pregnant women with PE. Plasma leptin levels in preeclamptic women were elevated significantly, compared with gestational age- and body mass index- matched normal pregnant women (P < 0.0001). Plasma leptin levels in the severe PE group were significantly higher than those in the mild PE group (P < 0.0001). Plasma leptin levels in preeclamptic women were reduced, soon after the placental delivery, to those expected for their body mass indices. Northern blot analysis revealed that leptin messenger RNA levels are increased in the placentas from preeclamptic women, compared with normal pregnant women. Leptin secretion was increased significantly in a human trophoblastic cell line (BeWo cells) cultured under hypoxic conditions (5{\%} O2), compared with those cultured under standard conditions (20{\%} O2; P < 0.01). The present study demonstrated that placental production of leptin is augmented in severe PE, probably because of placental hypoxia, thereby suggesting the possible significance of leptin as a marker of placental hypoxia in severe PE.",
author = "Hiroko Mise and Norimasa Sagawa and Tsunekazu Matsumoto and Shigeo Yura and Hidetaka Nanno and Hiroaki Itoh and Takahide Mori and Hiroaki Masuzaki and Kiminori Hosoda and Yoshihiro Ogawa and Kazuwa Nakao",
year = "1998",
month = "11",
day = "14",
doi = "10.1210/jc.83.9.3225",
language = "English",
volume = "83",
pages = "3225--3229",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Augmented placental production of leptin in preeclampsia

T2 - Possible involvement of placental hypoxia

AU - Mise, Hiroko

AU - Sagawa, Norimasa

AU - Matsumoto, Tsunekazu

AU - Yura, Shigeo

AU - Nanno, Hidetaka

AU - Itoh, Hiroaki

AU - Mori, Takahide

AU - Masuzaki, Hiroaki

AU - Hosoda, Kiminori

AU - Ogawa, Yoshihiro

AU - Nakao, Kazuwa

PY - 1998/11/14

Y1 - 1998/11/14

N2 - Preeclampsia (PE) is a hypertensive disorder, which develops in late pregnancy and is usually associated with placental hypoxia and dysfunction. We have recently demonstrated that leptin is a novel placenta-derived hormone in humans and suggested its significance in human pregnancy (see Ref. 19). To explore the changes in the leptin production in placenta in PE, we measured the plasma leptin level and placental leptin messenger RNA expression in pregnant women with PE. Plasma leptin levels in preeclamptic women were elevated significantly, compared with gestational age- and body mass index- matched normal pregnant women (P < 0.0001). Plasma leptin levels in the severe PE group were significantly higher than those in the mild PE group (P < 0.0001). Plasma leptin levels in preeclamptic women were reduced, soon after the placental delivery, to those expected for their body mass indices. Northern blot analysis revealed that leptin messenger RNA levels are increased in the placentas from preeclamptic women, compared with normal pregnant women. Leptin secretion was increased significantly in a human trophoblastic cell line (BeWo cells) cultured under hypoxic conditions (5% O2), compared with those cultured under standard conditions (20% O2; P < 0.01). The present study demonstrated that placental production of leptin is augmented in severe PE, probably because of placental hypoxia, thereby suggesting the possible significance of leptin as a marker of placental hypoxia in severe PE.

AB - Preeclampsia (PE) is a hypertensive disorder, which develops in late pregnancy and is usually associated with placental hypoxia and dysfunction. We have recently demonstrated that leptin is a novel placenta-derived hormone in humans and suggested its significance in human pregnancy (see Ref. 19). To explore the changes in the leptin production in placenta in PE, we measured the plasma leptin level and placental leptin messenger RNA expression in pregnant women with PE. Plasma leptin levels in preeclamptic women were elevated significantly, compared with gestational age- and body mass index- matched normal pregnant women (P < 0.0001). Plasma leptin levels in the severe PE group were significantly higher than those in the mild PE group (P < 0.0001). Plasma leptin levels in preeclamptic women were reduced, soon after the placental delivery, to those expected for their body mass indices. Northern blot analysis revealed that leptin messenger RNA levels are increased in the placentas from preeclamptic women, compared with normal pregnant women. Leptin secretion was increased significantly in a human trophoblastic cell line (BeWo cells) cultured under hypoxic conditions (5% O2), compared with those cultured under standard conditions (20% O2; P < 0.01). The present study demonstrated that placental production of leptin is augmented in severe PE, probably because of placental hypoxia, thereby suggesting the possible significance of leptin as a marker of placental hypoxia in severe PE.

UR - http://www.scopus.com/inward/record.url?scp=7844225512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7844225512&partnerID=8YFLogxK

U2 - 10.1210/jc.83.9.3225

DO - 10.1210/jc.83.9.3225

M3 - Article

C2 - 9745432

AN - SCOPUS:7844225512

VL - 83

SP - 3225

EP - 3229

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -